Beyond Conventional Monoclonals: Novel Antibody Formats and Derivatives as the Next Frontier in Cancer Therapy

Chemotherapy · Published 2026-06-29 · DOI 10.1159/000553142

Authors (5)

Rossana Roncato, Diletta Pasin, Emanuela Dell'Aquila, Romano Danesi, Marzia Del Re

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Roncato, R., Pasin, D., Dell'Aquila, E., et al. (2026). Beyond Conventional Monoclonals: Novel Antibody Formats and Derivatives as the Next Frontier in Cancer Therapy. Chemotherapy. https://doi.org/10.1159/000553142

Related articles